202 related articles for article (PubMed ID: 23484396)
41. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
42. [HPV immunization for the prevention of cervical cancer].
Mougin C; Bourgault-Villada I; Coursaget P
Presse Med; 2009 Dec; 38(12):1750-68. PubMed ID: 19765945
[TBL] [Abstract][Full Text] [Related]
43. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
Haupt RM; Sings HL
J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccine: a paradigm shift for pediatricians.
Jenson HB
Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
[TBL] [Abstract][Full Text] [Related]
45. Initial lessons learned in HPV vaccination.
Herzog TJ; Huh WK; Downs LS; Smith JS; Monk BJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S4-11. PubMed ID: 18482557
[TBL] [Abstract][Full Text] [Related]
46. Long-term efficacy of human papillomavirus vaccination.
Ault KA
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S27-30. PubMed ID: 17938016
[TBL] [Abstract][Full Text] [Related]
47. Acceptability of HPV vaccination among young adults aged 18-30 years--a population based survey in Sweden.
Sundström K; Tran TN; Lundholm C; Young C; Sparén P; Dahlström LA
Vaccine; 2010 Nov; 28(47):7492-500. PubMed ID: 20851088
[TBL] [Abstract][Full Text] [Related]
48. Modelling patterns of clearance of HPV-16 infection and vaccination efficacy.
Baussano I; Garnett G; Segnan N; Ronco G; Vineis P
Vaccine; 2011 Feb; 29(6):1270-7. PubMed ID: 21145375
[TBL] [Abstract][Full Text] [Related]
49. [Primary prevention of cervical carcinoma].
Hrgović Z; Izetbegović S
Med Arh; 2007; 61(1):49-51. PubMed ID: 17582978
[TBL] [Abstract][Full Text] [Related]
50. Innovations in HPV vaccination and roles of nurses in cervical cancer prevention.
Yildirim JG; Arabaci Z
Asian Pac J Cancer Prev; 2014; 15(23):10053-6. PubMed ID: 25556424
[TBL] [Abstract][Full Text] [Related]
51. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
Temkin SM; Seibel NL
Cancer; 2015 Oct; 121(19):3395-402. PubMed ID: 26110510
[TBL] [Abstract][Full Text] [Related]
52. Recommendations of the Polish Society of HPV Infections Prophylaxis - (PS-HPVIP) (Polskie towarzystwo profilaktyki zakazen HPV - PTPZ-HPV) concerning the use of preventive vaccines against HPV.
Majewski S; Wysocki J; Sikorski M; Niemiec T; Jackowska T;
Med Wieku Rozwoj; 2008; 12(2 Pt 1):621-5, 627-31. PubMed ID: 19301511
[No Abstract] [Full Text] [Related]
53. [Vaccine against human papilloma virus].
Juárez-Albarrán AC; Juárez-Gámez CA
Rev Med Inst Mex Seguro Soc; 2008; 46(6):631-7. PubMed ID: 19263667
[TBL] [Abstract][Full Text] [Related]
54. HPV vaccination.
Stanley M; O'Mahony C; Barton S
BMJ; 2014 Jul; 349():g4783. PubMed ID: 25073784
[No Abstract] [Full Text] [Related]
55. Recent advances in prophylactic human papillomavirus (HPV) vaccination: a review of key literature published between September 2017 and September 2018.
Šterbenc A; Maver PJ; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Dec; 27(4):193-201. PubMed ID: 30564832
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus vaccination in HIV-infected women: need for increased coverage.
Kojic EM; Rana AI; Cu-Uvin S
Expert Rev Vaccines; 2016; 15(1):105-17. PubMed ID: 26599305
[TBL] [Abstract][Full Text] [Related]
57. HPV vaccination rates remain low: cancer prevention community needs to continue promoting the vaccine's safety and efficacy, say experts.
Printz C
Cancer; 2015 May; 121(9):1341-3. PubMed ID: 25902756
[No Abstract] [Full Text] [Related]
58. [Vaccination against the human papilloma virus: a commitment of everybody].
Redondo Margüello E
Semergen; 2012; 38(5):263-4. PubMed ID: 23544772
[No Abstract] [Full Text] [Related]
59. Why are patients uncertain about the human papillomavirus vaccine's effectiveness?
Alcaraz KI; Arnold LD
J Comp Eff Res; 2014 Jul; 3(4):321-3. PubMed ID: 25275227
[No Abstract] [Full Text] [Related]
60. [Preventive vaccines opposite to the virus of the human papilloma. A new hope against the cancer of the genital feminine tract].
Aragón JA
An R Acad Nac Med (Madr); 2007; 124(4):827-36; discussion 836-41. PubMed ID: 18592919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
